Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #5717
Reference
Drug alert no 12/2015
Name
Drug alert class 4 no 12 2015: caution in use [Pfizer Limited - Genotropin 5.3mg powder for solution for injection (GoQuick pre-filled pen)]
Categories
Scottish Government
Drug Alerts
Organization
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Pfizer Limited has notified of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, Finance, EHealth and Pharmaceuticals Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2015-12-09 00:00:00
Click to go back to homepage